| Literature DB >> 32294942 |
Seham Abdel-Shafi1, Abdul-Raouf Al-Mohammadi2, Taghreed N Almanaa3, Ahmed H Moustafa4, Tamer M M Saad5, Abdel-Rahman Ghonemey5, Immacolata Anacarso6, Gamal Enan1, Nashwa El-Gazzar1.
Abstract
There is a need to continue research to find out other anti-dermatophytic agents to inhibit causal pathogenic skin diseases including many types of tinea. We undertook the production, purification, and identification of an anti-dermatophytic substance by Streptomyces atrovirens. Out of 103 streptomycete isolates tested, only 20 of them showed antidermatophytic activity with variable degrees against Trichophyton tonsurans CCASU 56400 (T. tonsurans), Microsporum canis CCASU 56402 (M. canis), and Trichophyton mentagrophytes CCASU 56404 (T. mentagrophytes). The most potent isolate, S10Q6, was identified based on the tests conducted that identified morphological and physiological characteristics and using 16S rRNA gene sequencing. The isolate was found to be closely correlated to previously described species Streptomyces atrovirens; it was designated Streptomyces atrovirens KM192347 (S. atrovirens). Maximum antifungal activity of the strain KM192347 was obtained in modified starch nitrate medium (MSNM) adjusted initially at pH 7.0 and incubated at 30 °C in shaken cultures (150 rpm) for seven days. The antifungal compound was purified by using two steps protocol including solvent extraction and column chromatography. The MIC of it was 20µg/mL against the dermatophyte cultures tested. According to the data obtained from instrumental analysis and surveying the novel antibiotics database, the antidermatophytic substance produced by the strain KM192347 was characterized as an oxaborole-6-benzene sulphonamide derivative and designated oxaborole-6-benzene sulphonamide (OXBS) with the chemical formula C13H12 BNO4S. The crude OXBS didn't show any toxicity on living cells. Finally, the results obtained herein described another anti-dermatophytic substance named an OXBS derivative. .Entities:
Keywords: OXBS; S. atrovirens; antifungal activity; dermatophytes; streptomycetes
Year: 2020 PMID: 32294942 PMCID: PMC7235740 DOI: 10.3390/antibiotics9040176
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Actinomycte isolates with antidermatophytic activity against the tested dermatophyte strains (T. mentagrophytes, M. canis and T. tonsurans).
| Area of Soil Sample | Serial Number and Isolate Code | Cultivated Plant | Color of Aerial Mycelium | Antifungal Activity (Inhibition Zone Diameter by mm) | ||
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Zagazig (Z) | S1Z3 | Onion | Grey | - | - | 13.0 + 0.19 |
| S3Z8 | Onion | Green | 12.2 + 0.31 | - | - | |
| S3Z10 | Onion | Yellow | 10.6 + 0.23 | - | - | |
| S5Z16 | Maize | Grey | - | - | 10.4 + 0.33 | |
| S6Z19 | Maize | Yellow | 15.0 + 0.87 | - | 19.2 + 0.41 | |
| S7Z23 | Maize | Green | - | - | 11.0 + 0.34 | |
| Qenayat (Q) | S10Q5 | Onion | Grey | 13.8 + 0.45 | - | - |
| S10Q6 | Onion | Grey | 20.2 + 0.40 | 18.2 + 0.25 | 24.4 + 0.49 | |
| S12Q14 | Onion | Green | 11.5 + 0.61 | - | - | |
| Menya EL-Kamh (M) | S17M6 | Maize | Green | 18.4 + 0.33 | - | 20.1 + 0.33 |
| S19M11 | Maize | Green | - | - | 12.8 + 0.30 | |
| S20M16 | Maize | Grey | 13.9 + 0.43 | 12.9 + 0.52 | 17.6 + 0.62 | |
| S22M21 | Maize | Green | 10.3 + 0.41 | - | - | |
| S22M26 | Maize | Green | 21.0 + 0.39 | - | 21.9 + 0.45 | |
| S24M29 | Maize | White | 11.2 + 0.53 | - | - | |
| Belbis (B) | S26B4 | Maize | Grey | 9.8 + 0.31 | - | - |
| S26B6 | Maize | Yellow | 8.9 + 0.63 | - | - | |
| S27B9 | Onion | Green | 14.1 + 0.38 | - | 15.9 + 0.39 | |
| S27B10 | Onion | Grey | 12.0 + 0.43 | - | - | |
| S28B17 | Maize | Green | - | - | 11.4 + 0.23 | |
Isolate show antifungal activity against the dermatophyte strains (-, no inhibition zone). Z: Zagazig City; 84Kmnorth Cairo. Q: Qenayat City; 85 Km north Cairo. M: Menya El-Kamh; 78 Km north Cairo. B: Belbis City; 68 Km north Cairo.
Figure 1Characterization of Streptomyces atrovirens culture. (A): Spore chain morphology (1000×), (B): spore surface under electron microscope (18,000×).
The selection of optimum conditions necessary for anti-dermatophytic substance production by S. atrovirens.
| Parameter | Optimum Value | Inhibition Zone * (mm) | ||
|---|---|---|---|---|
|
|
|
| ||
|
| ||||
| Incubation Period (Days) | 7 | 40.0a ± 0.58 | 24.03b ± 0.26 | 26.17b ± 0.44 |
| pH | 7 | 39.27a ± 0.43 | 23.33b ± 0.6 | 24.87b ± 0.3 |
| Incubation Temperature (°C) | 30 | 40.03b ± 0.27 | 23.70c ± 0.75 | 26.23b ± 0.38 |
| Agitation Rate (rpm) | 150 | 55.23a ± 0.42 | 22.5c ± 0.36 | 26.77b ± 0.38 |
|
| ||||
| Carbon Source | Starch(20g/L) | 52.80a ± 0.57 | 31.47c ± 0.26 | 34.63b ± 0.45 |
| Nitrogen Source | Potassium Nitrate (2g/L) | 52.37a ± 0.24 | 31.53c ± 0.29 | 35.33b ± 0.2 |
| Phosphorus Source | DipotassiumHydrogen Phosphate (1g/L) | 55.00a ± 0.25 | 32.73c ± 0.15 | 36.70b ± 0.65 |
| Sodium Chloride Concentration (g/L) | 0.5 g/L | 50.73a ± 0.13 | 29.90c ± 0.21 | 33.43b ± 0.3 |
* Each value is an average of three replicates ± standard error (SE). Mean in the same row having different letters are significantly different (p ≤ 0.01).
Figure 2Phylogenetic tree showing the dendrogarm of the clusters analysis of some selected strains mentioned in the tree from the revelant taxa; the S10Q6 isolate existed within S. atrovirens cluster (99% similarity). The accession number KM192347 of NCBI web server (www.ncbi.nlm.nih.gov).
Minimum inhibitory concentration (MIC) values of the antifungal compound produced by S. atrovirens.
| Concentration μg/mL | Growth of the Indicator Dermatophytes | ||
|---|---|---|---|
|
|
|
| |
| 100 |
|
|
|
| 80 |
|
|
|
| 60 |
|
|
|
| 40 |
|
|
|
| 20 |
|
|
|
| 10 |
|
|
|
| Negative Control |
|
|
|
| Ketoconazole (10 μg/disc) |
|
|
|
−: No growth. +: positive growth.
Figure 3Extraction and purification of the antidermatophytic substance(s) produced by S. atrovirens (A); Antidermatophytic activity as showed by inhibition zone diameter of different solvent extracts of S. atrovirens; fractions eluted using column chromatography respectively (B). Results are the average of three replicates ± SE.
Figure 4Elucidation of the structure of the antifungal substance(s). (A): Infrared (IR) spectrum of the antifungal compound produced by S.atrovirensKM192347. (B): 1H NMR spectrum of the antifungal compound produced by S. atrovirens KM192347 (DMSO-N6).
Figure 5Structural formula of oxaborole-6-benzene sulphonamide (OXBS) derivative produced by S. atrovirens.
Figure 6Liver sections from male Albino rats, X400. (A); control and (B) treated with OXBS by oral route. CV: central vein, HS: hepatic stand, BS: blood sinusoids, and KF: Kupffer cells.